Bottom Fishing in the California Laboratory Market
Just when it looked like the California reference laboratory scene couldn't be worse-three of the largest labs in the state are in or near bankruptcy, a hospital-reference lab partnership is splitting up, and few, if any, made money last year-along comes a buyer for two of the more distressed properties.
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.